Ki Sun Jung

603 total citations
21 papers, 347 citations indexed

About

Ki Sun Jung is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ki Sun Jung has authored 21 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ki Sun Jung's work include Multiple Myeloma Research and Treatments (3 papers), Peptidase Inhibition and Analysis (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Ki Sun Jung is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Peptidase Inhibition and Analysis (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Ki Sun Jung collaborates with scholars based in South Korea and United States. Ki Sun Jung's co-authors include Kwai Han Yoo, Sung Hee Lim, Se‐Hoon Lee, Haa‐Na Song, Hae Su Kim, Ji Yun Lee, Jin Seok Ahn, Seok Jin Kim, Jong‐Mu Sun and Myung‐Ju Ahn and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Ki Sun Jung

21 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ki Sun Jung South Korea	10	201	153	146	82	40	21	347
Atsushi Nagase Japan	8	135 0.7×	228 1.5×	210 1.4×	43 0.5×	27 0.7×	22	383
Jérôme Alexandre France	3	296 1.5×	174 1.1×	139 1.0×	78 1.0×	57 1.4×	4	445
Anna Johnson United States	14	165 0.8×	244 1.6×	95 0.7×	90 1.1×	84 2.1×	38	408
Toshikazu Okaneya Japan	12	141 0.7×	152 1.0×	124 0.8×	47 0.6×	40 1.0×	51	423
Yasuhiro Arakawa Japan	11	150 0.7×	86 0.6×	159 1.1×	94 1.1×	22 0.6×	37	380
Michalis Michael Greece	13	225 1.1×	72 0.5×	229 1.6×	42 0.5×	55 1.4×	22	492
Guo Long China	13	213 1.1×	152 1.0×	170 1.2×	165 2.0×	20 0.5×	26	492
Mohamad Khasawneh United States	6	181 0.9×	223 1.5×	93 0.6×	106 1.3×	27 0.7×	8	333
Lola Luo United States	8	128 0.6×	69 0.5×	113 0.8×	62 0.8×	22 0.6×	8	403
Tristan Maurina France	10	118 0.6×	154 1.0×	108 0.7×	73 0.9×	34 0.8×	30	293

Countries citing papers authored by Ki Sun Jung

Since Specialization

Citations

This map shows the geographic impact of Ki Sun Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ki Sun Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ki Sun Jung more than expected).

Fields of papers citing papers by Ki Sun Jung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ki Sun Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ki Sun Jung. The network helps show where Ki Sun Jung may publish in the future.

Co-authorship network of co-authors of Ki Sun Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Ki Sun Jung. A scholar is included among the top collaborators of Ki Sun Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ki Sun Jung. Ki Sun Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Dong-Jin, Yeuni Yu, Ki Sun Jung, Yun Hak Kim, & Jae‐Joon Kim. (2023). Tumor Microenvironment Can Predict Chemotherapy Response of Patients with Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy. Cancer Research and Treatment. 56(1). 162–177. 11 indexed citations

Kim, Jae-Joon, et al.. (2023). Effect of tumor microenvironment on chemotherapy response of patients with triple-negative breast cancer receiving neoadjuvant chemotherapy.. Journal of Clinical Oncology. 41(16_suppl). 590–590. 1 indexed citations

Song, Ga‐Young, Dok Hyun Yoon, Cheolwon Suh, et al.. (2020). Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma. Bone Marrow Transplantation. 56(5). 1205–1208. 10 indexed citations

Park, Eun Ju, Kwonoh Park, Jae‐Joon Kim, et al.. (2020). Safety, Efficacy, and Patient Satisfaction with Initial Peripherally Inserted Central Catheters Compared with Usual Intravenous Access in Terminally Ill Cancer Patients: A Randomized Phase II Study. Cancer Research and Treatment. 53(3). 881–888. 13 indexed citations

Jung, Ki Sun, Kihyun Kım, Hyo Jung Kim, et al.. (2019). Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study. Clinical Lymphoma Myeloma & Leukemia. 20(2). e97–e104. 3 indexed citations

Shin, Ho‐Jin, et al.. (2019). Dose Adjustment Helps Obtain Better Outcomes in Multiple Myeloma Patients with Bortezomib, Melphalan, and Prednisolone (VMP) Treatment. Turkish Journal of Hematology. 36(2). 106–111. 2 indexed citations

Kim, Yoo‐Mi, et al.. (2019). Identification of a Novel MYH9 Mutation in a Young Adult With Inherited Thrombocytopenia and Recurrent Seizures by Targeted Exome Sequencing. Journal of Pediatric Hematology/Oncology. 42(3). e188–e192. 1 indexed citations

Jung, Ki Sun, Yoo‐Jin Kim, Yeo-Kyeoung Kim, et al.. (2019). Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System. Clinical Lymphoma Myeloma & Leukemia. 19(10). 656–664. 4 indexed citations

Jung, Ki Sun, Jeeyun Lee, Se Hoon Park, et al.. (2017). Pilot study of sirolimus in patients with PIK3CA mutant/amplified refractory solid cancer. Molecular and Clinical Oncology. 7(1). 27–31. 15 indexed citations

10.

Jung, Ki Sun, Su Jin Lee, Se Hoon Park, et al.. (2017). Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study. Cancer Research and Treatment. 50(2). 488–494. 36 indexed citations

11.

Lee, Ji Yun, Won Jin Chang, Sung Hee Lim, et al.. (2016). MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis. Oncotarget. 7(28). 43492–43503. 48 indexed citations

12.

Jung, Ki Sun, et al.. (2016). Clinical features and treatment outcome of Epstein–Barr virus-positive nodal T-cell lymphoma. International Journal of Hematology. 104(5). 591–595. 21 indexed citations

13.

Kim, Hee Kyung, Seonggyu Byeon, Kwai Han Yoo, et al.. (2016). Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea. Cancer Research and Treatment. 48(4). 1382–1388. 9 indexed citations

14.

Cho, Jinhyun, Soomin Ahn, Kwai Han Yoo, et al.. (2016). Correlation between PD-L1 expression and PD-1 immune checkpoint blockade: A retrospective analysis for advanced melanoma.. Journal of Clinical Oncology. 34(15_suppl). e21007–e21007. 1 indexed citations

15.

Jung, Ki Sun, Jinhyun Cho, Kwai Han Yoo, et al.. (2016). Pazopanib for treatment of metastatic renal cell carcinoma with non-clear cell histology: Single-arm, open label, multicenter, phase II study.. Journal of Clinical Oncology. 34(2_suppl). 577–577. 3 indexed citations

16.

Lee, Ji Yun, Jong‐Mu Sun, Sung Hee Lim, et al.. (2015). A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non–Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib. Clinical Cancer Research. 22(9). 2139–2145. 28 indexed citations

17.

Song, Haa‐Na, Ki Sun Jung, Kwai Han Yoo, et al.. (2015). Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 11(4). e45–e47. 92 indexed citations

18.

Park, Silvia, Kihyun Kım, Jun Ho Jang, et al.. (2015). Randomized Trial of Micafungin Versus Fluconazole in Prophylaxis Against Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients. Blood. 126(23). 1904–1904. 1 indexed citations

19.

Kim, Do Hee, Ahyoung Lim, Hye Bin Gwag, et al.. (2014). A case of Fanconi syndrome accompanied by crystal depositions in tubular cells in a patient with multiple myeloma. Kidney Research and Clinical Practice. 33(2). 112–115. 2 indexed citations

20.

Jung, Ki Sun, H.S. Kim, Jin Yong Lee, et al.. (2014). Phase Ii Study of a Combination Chemotherapy with Weekly Docetaxel and Gemcitabine in Previously Treated Metastatic Esophageal Squamous Cell Cancer. Annals of Oncology. 25. iv231–iv231. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact